Detalhe da pesquisa
1.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-up From a Phase 3 Trial.
J Urol
; : 101097JU0000000000004020, 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704840
2.
Detection of PD-L1-Expressing Myeloid Cell Clusters in the Hyaluronan-Enriched Stroma in Tumor Tissue and Tumor-Draining Lymph Nodes.
J Immunol
; 208(12): 2829-2836, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589125
3.
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Lancet Oncol
; 22(1): 107-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253641
4.
Patient and Procedural Determinants of Postoperative Pain Trajectories.
Anesthesiology
; 134(3): 421-434, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449996
5.
Slow Dynamics of Acute Postoperative Pain Intensity Time Series Determined via Wavelet Analysis Are Associated With the Risk of Severe Postoperative Day 30 Pain.
Anesth Analg
; 132(5): 1465-1474, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33591118
6.
Mechanisms of immune evasion in bladder cancer.
Cancer Immunol Immunother
; 69(1): 3-14, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811337
7.
8.
Metabolic bone disease following urinary diversion in adults.
Curr Opin Urol
; 24(6): 614-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25203244
9.
Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma.
Urol Oncol
; 2024 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38802293
10.
Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons.
BJU Int
; 111(5): 731-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22502641
11.
Tissue Slice Culture and Analysis of Tumor-Associated Hyaluronan in Urothelial Carcinoma.
Methods Mol Biol
; 2684: 167-175, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410234
12.
Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma.
Cancer
; 118(18): 4412-20, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22952032
13.
Enhancing renal tumors in patients with prior normal abdominal imaging: further insight into the natural history of renal cell carcinoma.
J Urol
; 188(4): 1089-93, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22901590
14.
Association of tumor size, location, R.E.N.A.L., PADUA and centrality index score with perioperative outcomes and postoperative renal function.
J Urol
; 188(5): 1684-9, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22998902
15.
Role of cytoreductive nephrectomy in the era of targeted therapy for renal cell carcinoma.
Curr Urol Rep
; 13(1): 38-46, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22105577
16.
NMP-22, urinary cytology, and cystoscopy: a 1 year comparison study.
Can J Urol
; 19(4): 6345-50, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22892257
17.
High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma.
J Kidney Cancer VHL
; 9(2): 1-6, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35528727
18.
Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
Cancers (Basel)
; 15(1)2022 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612164
19.
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial.
Eur Urol
; 81(3): 223-228, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933753
20.
Treatment of patients with small renal masses: a survey of the American Urological Association.
J Urol
; 185(2): 407-13, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21168170